EV-based Liquid Biopsy Market worth $349.19 Million by 2031 - Exclusive Report by InsightAce Analytic

Extracellular Vesicles (EVs) are released by every body cell, which is a snapshot of cellular biological activity. They can be in biofluids such as blood and provide the best way to detect and prevent non-invasive diseases, including cancer. EV-based liquid biopsy holds great promise for cancer diagnosis, prognosis and clinical monitoring. However, it is still necessary to provide precise EV subtype classification, standardized protocols, and larger patient cohort studies for further clinical translation.

Extracellular Vesicles (EVs) are released by every body cell, which is a snapshot of cellular biological activity. They can be in biofluids such as blood and provide the best way to detect and prevent non-invasive diseases, including cancer. EV-based liquid biopsy holds great promise for cancer diagnosis, prognosis and clinical monitoring. However, it is still necessary to provide precise EV subtype classification, standardized protocols, and larger patient cohort studies for further clinical translation.

Almost all EVs seen in the blood are from blood cells, such as platelets, red blood cells, or immune cells, and a small percentage are from tissues such as the liver, lungs, or kidneys. Conventional isolation techniques cannot distinguish between EVs based on their origin, thus limiting progress in disease biomarker discovery. Thus, many pharmaceutical companies are focusing on developing a novel and robust method to isolate tissue-specific EVs from blood to address these challenges.

Request for Sample Pages:https://www.insightaceanalytic.com/request-sample/1920  

  Some of the prominent players in the EV-based Liquid Biopsy Market are:

EV-based Liquid Biopsy Market Report Scope

 

Curious about this latest version of the report? Enquiry Before Buying:https://www.insightaceanalytic.com/enquiry-before-buying/1920 

Market Dynamics:

Drivers:

The increasing number of cancer cases is surging the demand for liquid biopsy.

The EV-based liquid biopsy market is mainly driven by the high prevalence of cancer and rising public awareness about the different non-invasive treatments. As per the data provided by WCRF International (World Cancer Research Fund International), nearly 18.1 million cancer cases worldwide were reported in 2020. Thus, the high prevalence of cancer is expected to enhance the demand for EV-based liquid biopsy techniques during the forecast period.

Moreover, the increasing investments by market players in clinical trials to develop new diagnostic tests, high demand for personalized medicine, modifications in medical technologies, and growing R&D efforts in clinical oncology contribute to the market's growth.

Challenges:

However, the lack of standardized and clinically feasible EV purification & characterization protocols hinders the applicability of EV-based cancer biomarker analysis, which is expected to restrict the growth of the EV-based Liquid Biopsy Market in the coming years.

Regional Trends:

North America accounted for the maximum revenue share of the EV-based Liquid Biopsy Market in 2022. This is primarily due to the increasing prevalence of cancer in this region. In addition, growing demand for personalized therapies, increasing healthcare expenditure, and rising cancer research investments have boosted market growth. On the other hand, Asia Pacific is predicted to be the fastest-growing market over the forecast period. This is attributable to the increasing public awareness regarding liquid biopsy applications, well-established healthcare infrastructure, and rising adoption of advanced medical techniques in hospitals, clinics, and diagnostic laboratories for diagnosis.

Key developments in the market:

Market Segments

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Offering

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Workflow

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Sample Type

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End User

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region

North America EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031

Europe EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031

Asia Pacific EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031

Latin America EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031

Middle East & Africa EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031

Obtain Report Customization Details @https://www.insightaceanalytic.com/customisation/1920 

Why should buy this report:

Other Related Reports Published by InsightAce Analytic:

Multi Cancer Early Detection Market

Proteomics Market

Cancer Diagnostics Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.

Contact Us:

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/ev-based-liquid-biopsy-market-worth-349-19-million-by-2031---exclusive-report-by-insightace-analytic-301885251.html